Elanco Animal Health recently acquired Prevtec Microbia, a biotechnology startup that develops vaccines to help prevent bacterial diseases in food-production animals. Elanco is partnering with companies to introduce antibiotic alternatives through internal or external innovation pathways.
Among Prevtec's products is Coliprotec, a vaccine to protect pigs against post-weaning diarrhea and associated symptoms caused by Escherichia coli. Elanco was the exclusive distributor for Coliprotec in Canada and Europe. The new acquisition will enable Elanco to expand registration to other geographies. Elanco acquired Prevtec Microbia for about $60 million.